Catalyst
Slingshot members are tracking this event:
Data from Phase 3b ENSURE-AF Study Investigating Once-Daily SAVAYSA (edoxaban) in Patients with Atrial Fibrillation Undergoing Cardioversion Among 13 Daiichi Sankyo Clinical Presentations at ESC Congress 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| D4S.F |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 24, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Ensure-af Study, Savaysa, Edoxaban, Atrial Fibrillation
